EROS: Engendering reproductive health within oncologic survivorship—ECOG-ACRIN E1Q11 paradoxical provision of reproductive health.

• DOI: 10.1200/jco.2024.42.16_suppl.11123
• Publication Date: 2024-06-03T20:28:50Z
• Authors: Ashlesha Patel; Ju-Whei Lee; Howard A. Zaren; Erika K Radeke; Rachel E. Lerner; Jami Aya Fukui; Della F. Makower; Deimante Tamkus; Kendrith M. Rowland; William M. Adler; Alyssa Throckmorton; sharad A. ghamande; Jessica Jones Croley; Andrew William Pi...; Rubina Qamar; Michael Jordan Fisch; David Cella; Lynne I. Wagner; Mary Helen Helen ...
• Keywords: Cancer Survivorship

11123 Background: For the 10% of women diagnosed with cancer in reproductive age, health (RH) is a critical component oncologic survivorship. RH includes oncocontraception (OC), oncofertility (OF) and sexuality. Guidelines segregate these components resulting fragmented care management. Methods: The EROS trial clustered randomized performed at 17 NCI Community Oncology Research Program (NCORP) sites (including 8 NCORP 9 Minority/Underserved sites) from 2016-2023. Eligible subjects included reproductively capable aged 15-55 new diagnosis. Intervention didactics decision aids. Childbearing interest was dichotomous, not completed childbearing either pregnant or future interest) childbearing. objective this study to determine provision OC OF referral by providers baseline visit based on patient’s self-reported entry. Chi-square tests were used compare distribution differences status (receipt: yes vs. no) between treatment arms. Results: enrolled 420 subjects. Of 63.6% (267/420) childbearing, 62.4% (58/93) intervention arm 40.2% (70/174) non-intervention received an (p=0.0006), whereas 98.9% (92/93) 93.7% (163/174) (p=0.0487). 36.4% (153/420) 48.3% (28/58) 33.72% (32/95) (p=0.0729), while 77.6% (45/58) 70.5% (67/95) (p=0.3388). Conclusions: While increased rates for patients our shows referrals markedly higher rate than oncontraception. Referral patterns inconsistent patient need particularly (receiving referral) delayed (not receiving patient. bias favoring may reflect oncology guidelines emphasizing aspect despite comprehensive needs